Warsaw-based Jutro Medical, an AI-first primary care provider integrating online and offline care, has raised €12 million in Series A funding to expand their physical footprint across Europe – opening its first clinic in the Netherlands.
The round was led by KAYA VC and RIO ASI, with participation from existing investor Inovo VC. The funding also includes a debt component provided by mBank.
“When you break down complex healthcare delivery into hundreds of tasks done daily by the doctors and medical staff, you discover that only a tiny part of these tasks have anything to do with medicine and health. We’ve been dissecting these processes and turning them into skills that we can teach AI agents, so they can handle them end-to-end, shifting all operational tasks and red tape from human to AI. We are building medical AI agents who can take over all these tasks from doctors, allowing them to finally practice medicine”, says Adam Janczewski, CEO & Founder of Jutro Medical.
Founded in 2020 by Adam Janczewski, with a goal of delivering exceptional medical care with technology that actually delivers value, Jutro Medical is a primary care provider for 70,000 patients. After 400,000 visits, the average visit rating on a 1–5 scale is 4.93, the NPS stands at 86, and the PMF score at 77% – according to data provided by Jutro Medical.
Jutro Medical is an AI-first primary care clinic with its own medical AI agents, which can handle over 68% of teleconsultations.
Patients start their appointments by chatting with an AI agent that collects necessary information and completes post-visit documentation, enabling doctors to concentrate on patient treatment. For straightforward medical cases, the AI agent reportedly reduces appointment time with a median duration of 2 minutes and 37 seconds.
Medical AI agents have been built on top of Jutro Medical’s proprietary electronic health record system, developed by the company from its inception to securely store patient data. Initially, these processes were performed by human agents during intake interviews before doctor consultations, ensuring the workflow was tested and validated through human interactions before being transitioned to AI.
To ensure safety, medical AI agents are supervised by doctors, who remain solely responsible for medical decisions and analysing information gathered by the AI. Jutro Medical ensures that all patient data remains private and secure, as the LLM models powering the AI agents are developed and hosted internally by Jutro Medical.
Medical AI agents are an optional feature for the patients who opt in to the AI tools. If they choose not to, they can still have their doctor appointments in a more traditional way, either online or offline.
“AI will benefit incumbents, and Adam has positioned Jutro Medical to capture maximum value as the technology matures. He has quietly tested what’s possible using LLMs, with 30 people acting as medical agents, to map processes directly into the company’s proprietary electronic health record system. We’re excited to partner with Adam and his team as they transform healthcare services into AI-powered software products, directly benefiting patients and doctors,” says Karel Zheng, Partner at KAYA VC.
The funding will also be used to expand Jutro Medical’s physical footprint across Europe. The company is soon opening its first clinic in the Netherlands and will continue expanding in Poland. Jutro Medical aims to take care of 350k European lives within the next 24 months.
To achieve these goals, Jutro Medical has teamed up with experienced healthcare executives responsible for overseeing 227 clinics and contributing to €450 million in primary care revenue over the past decade.
They include Bartosz Skawiński (CFO) and Konrad Michalski (Medical Director), who previously helped build PZU Zdrowie into Poland’s third-largest healthcare provider, and Marek Maleszyk (COO), who previously grew a primary care network from just one facility to 85 clinics with 2,000 employees, also as a COO.
“Jutro Medical has proven that primary care can be delivered differently—leveraging technology to provide high-quality medical care focused on patient value, all free of charge under Europe’s mandatory public health insurance. Adam and his team have built a vertically integrated healthcare provider covering the entire value chain. With their proprietary AI agents, they’re set to disrupt primary care across Europe, and I’m glad to support them on this journey,” says Piotr Siezieniewski, Partner at RIO ASI.
